Project Grant R37CA295618
Award Date 8/1/25
Completion Date 7/31/30
Dollars Obligated $621K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
- The National Cancer Institute (NCI) awarded a $1,684,165 Cooperative Agreement under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) to Kaiser Foundation Hospitals. The project, titled "Expanding Lung Cancer Screening to Achieve Excellence (EXHALE)", aims to develop and evaluate implementation strategies to increase guideline-concordant lung cancer screening in Federally Qualified Health Centers (FQHCs). The project will form a partnership between 7 FQHC...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a 5-year, $378,405 Project Grant to Oregon Health & Science University (OHSU) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353). The grant will fund research to characterize the nuclear pore complex protein NUP205 as a haploinsufficient essential gene that contributes to hematopoietic (blood cell) malignancies associated with chromosome 7 deletion or...
- This Project Grant award of $1,131,820.00 from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) supports research to characterize toxicities and health-related quality of life outcomes among a diverse sample of 416 individuals receiving immune checkpoint inhibitor treatment for metastatic cancer. The study aims to examine associations between patient sociodemographic/medical factors and symptomatic toxicities and quality of...
- This $175,978 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research by the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to study the role of ARID1A mutations in intrahepatic cholangiocarcinoma. The award period is from August 1, 2024 to July 31, 2026. The funding will support the organization's biomedical research and provision of medical care services related to...
- The National Cancer Institute (NCI) awarded a $697,198 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to the University of California, San Diego (UC San Diego Health) for the project "Optimal Early Colorectal Cancer Screening Initiation" from January 1, 2025 to December 31, 2027. The grant supports research to develop a targeted colorectal cancer screening strategy for adults aged 45-49, with the goal of maximizing screening uptake and...
- This federal Project Grant award of $505,613, provided by the National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research), will support the development of statistical and computational approaches to harness genomic data and translate findings into precision prevention strategies for cancer. The key objectives are to: Develop deep learning-based methods to identify tumor subtypes linked to adverse outcomes and robust data integration approaches to assess associations between...
- This federal Project Grant award of $652,799 from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research at the Fred Hutchinson Cancer Center in Seattle, Washington to investigate the mechanistic details of a cancer-specific phenomenon called "MAPK-Driven Kinetochore Stress" (MASKS). The overarching goal is to reveal the role of oncogenic signaling pathways in destabilizing kinetochore-microtubule attachments, which can lead to chromosome instability in...
- This $192,888 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports a research project at the University of Virginia (UVA) to investigate the use of normal colon organoids for identifying causal genetic variants associated with colorectal cancer risk. The key objectives of the project are to: 1) test the hypothesis that colorectal cancer GWAS genes are cell type-specific, and 2) determine the role of these genes within colon epithelial...
- The federal Project Grant award of $1,578,836.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) in developing and exploiting a third-generation prostate cancer dependency map to identify cancer vulnerabilities and treatment targets. The award, which runs from August 1, 2024 to July 31, 2027, will enable the research organization to conduct innovative...
- The National Cancer Institute (NCI), through the Cancer Cause and Prevention Research Program (CFDA 93.393), awarded a $2,124,826 Project Grant to President and Fellows of Harvard College (Harvard T.H. Chan School of Public Health) to optimize a mobile messaging intervention for increasing colorectal cancer (CRC) screening rates among patients at community health centers. The project aims to use a two-phase process to first determine optimal messaging strategies for maximizing patient engagement...